Amlodipine Besylate and Olmesartran Medoxomil
8 NDCs across 1 manufacturer|8 Generic,0 Brand
▸ More about this market▾ Less
Amlodipine Besylate and Olmesartran Medoxomil is available as 8 NDCs from 1 manufacturer (8 generic, 0 brand), with NADAC prices from $0.23 to $0.32 per EA — a 40% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
8
8G / 0B
Manufacturers
1
competing in market
Price Spread
$0.23 – $0.32
per EA
7d Activity
avg -3.2% WoW · of 8 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
AMLODIPINE-OLMESARTAN 10-40 MG | $0.3161 per EA | -4.06% |
AMLODIPINE-OLMESARTAN 10-40 MG | $0.3161 per EA | -4.06% |
AMLODIPINE-OLMESARTAN 5-40 MG | $0.3122 per EA | +3.12% |
AMLODIPINE-OLMESARTAN 5-40 MG | $0.3122 per EA | +3.12% |
AMLODIPINE-OLMESARTAN 10-20 MG | $0.2298 per EA | -4.31% |
AMLODIPINE-OLMESARTAN 10-20 MG | $0.2298 per EA | -4.31% |
AMLODIPINE-OLMESARTAN 5-20 MG | $0.2257 per EA | -7.69% |
AMLODIPINE-OLMESARTAN 5-20 MG | $0.2257 per EA | -7.69% |
Frequently Asked Questions
How many Amlodipine Besylate and Olmesartran Medoxomil products are on the market?
The Amlodipine Besylate and Olmesartran Medoxomil drug market contains 8 NDCs from 1 manufacturer — 8 generic and 0 brand products.
What is the price range for Amlodipine Besylate and Olmesartran Medoxomil?
NADAC reference prices for Amlodipine Besylate and Olmesartran Medoxomil range from $0.2257 to $0.3161 per EA — a 40% difference between cheapest and most expensive.
Which manufacturers make Amlodipine Besylate and Olmesartran Medoxomil?
1 manufacturer lists Amlodipine Besylate and Olmesartran Medoxomil in NADAC. Ranked by number of NDCs, the largest are Alembic Pharmaceuticals Inc. (8).
How has the price of Amlodipine Besylate and Olmesartran Medoxomil changed recently?
Over the past 7 days, 6 Amlodipine Besylate and Olmesartran Medoxomil NDCs rose and 18 fell, with a market-wide average change of -3.2%.